Bacterin That Induces Anti-OspA and Anti-OspC Borreliacidal Antibodies Provides a High Level of Protection against Canine Lyme Disease
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Groups of 15 laboratory-bred beagles were vaccinated and boosted with either a placebo or adjuvanted bivalent bacterin comprised of a traditional Borrelia burgdorferi strain and a unique ospA- and ospB-negative B. burgdorferi strain that expressed high levels of OspC and then challenged with B. burgdorferi-infected Ixodes scapularis ticks. The vaccinated dogs produced high titers of anti-OspA and anti-OspC borreliacidal antibodies, including borreliacidal antibodies specific for an epitope within the last seven amino acids at the OspC carboxy terminus (termed OspC7) that was conserved among pathogenic Borrelia genospecies. In addition, spirochetes were eliminated from the infected ticks that fed on the bacterin recipients,B. burgdorferi was not isolated from the skin or joints, and antibody responses associated specifically with canine infection with B. burgdorferi were not produced. In contrast,B. burgdorferi was recovered from engorged ticks that fed on 13 (87%) placebo-vaccinated dogs (P< 0.0001), skin biopsy specimens from 14 (93%) dogs (P< 0.0001), and joint tissue specimens from 8 (53%) dogs (P= 0.0022). In addition, 14 (93%) dogs developed specific antibody responses against B. burgdorferi proteins, including 11 (73%) with C6 peptide antibodies (P< 0.0001). Moreover, 10 (67%) dogs developed Lyme disease-associated joint abnormalities (P< 0.0001), including 4 (27%) dogs that developed joint stiffness or lameness and 6 (40%) that developed chronic joint inflammation (synovitis). The results therefore confirmed that the bacterin provided a high level of protection against Lyme disease shortly after immunization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, S. A., & Magnarelli, L. A. (1992) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1992.200.03.344 · Cited by 89
Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi
Chang, Y. F., Appel, M. J., Jacobson, R. H., Shin, S. J., Harpending, P., Straubinger, R., Patrican, L. A., Mohammed, H., & Summers, B. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.9.3543-3549.1995 · Cited by 76 · cited 1×
“The approach has been effective (8, 10, 31, 40), but the vaccines may also fail (23) because the expression of OspA is downregulated immediately after the infected tick begins acquiring a blood meal (36), borreliacidal antibodies specific for OspA are genospecies specific (28, 49), and ticks”
MethodPerformance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas
Levy, S. A., Lissman, B. A., & Ficke, C. M. (1993) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1993.202.11.1834 · Cited by 52
Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine
Straubinger, R. K., Dharma Rao, T., Davidson, E., Summers, B. A., Jacobson, R. H., & Frey, A. B. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00251-1 · Cited by 23
Safety, efficacy and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine
Ma, J., Hine, P. M., Clough, E. R., Fish, D., Coughlin, R. T., Beltz, G. A., & Shew, M. G. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00045-x · Cited by 21 · cited 1×
“The approach has been effective (8, 10, 31, 40), but the vaccines may also fail (23) because the expression of OspA is downregulated immediately after the infected tick begins acquiring a blood meal (36), borreliacidal antibodies specific for OspA are genospecies specific (28, 49), and ticks can be infected with varia…”
Background
Cited by
ACVIM consensus update on Lyme borreliosis in dogs and cats
Littman, M. P., Gerber, B., Goldstein, R. E., Labato, M. A., Lappin, M. R., & Moore, G. E. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15085 · Cited by 152
Vogt, N. A., Sargeant, J. M., MacKinnon, M. C., & Versluis, A. M. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15344 · Cited by 16
Grosenbaugh, D. A., Rissi, D. R., & Krimer, P. M. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.08.014 · Cited by 12
Metadata
- Authors
- LaFleur, R. L., Dant, J. C., Wasmoen, T. L., Callister, S. M., Jobe, D. A., Lovrich, S. D., Warner, T. F., Abdelmagid, O., & Schell, R. F.
- Venue
- Clinical and Vaccine Immunology
- Publisher
- American Society for Microbiology
- Published
- 2009-02
- Volume
- 16
- Issue
- 2
- Pages
- 253-259
- ISSN
- 1556-679X (ISSN-L)
- 1556-6811
- OpenAlex
- W2134555004
- Cited by
- 48
- References
- 5
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.